77 related articles for article (PubMed ID: 8558839)
1. Chronic administration of epidermal growth factor to pigs induces growth, especially of the urinary tract with accumulation of epithelial glycoconjugates.
Vinter-Jensen L; Juhl CO; Poulsen SS; Djurhuus JC; Dajani EZ; Nexø E
Lab Invest; 1995 Dec; 73(6):788-93. PubMed ID: 8558839
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of epidermal growth factor (EGF) with focus on the urinary and gastrointestinal tracts.
Vinter-Jensen L
APMIS Suppl; 1999; 93():1-42. PubMed ID: 10424202
[TBL] [Abstract][Full Text] [Related]
3. Ureteric growth in a Goettingen minipig induced by epidermal growth factor. A case report.
Vinter-Jensen L; Juhl CO; Djurhuus JC; Dajani EZ; Teglbjaerg PS; Uvelius B; Nexø E
Scand J Urol Nephrol Suppl; 1995; 172():109-15. PubMed ID: 8578247
[TBL] [Abstract][Full Text] [Related]
4. Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates.
Vinter-Jensen L; Juhl CO; Djurhuus JC; Poulsen SS; Dajani EZ; Brown KD; Orntoft TF; Teglbjaerg PS; Nexø E
Am J Pathol; 1995 Nov; 147(5):1330-8. PubMed ID: 7485396
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of epidermal growth factor (EGF) and EGF receptors in the porcine upper gastrointestinal tract.
Jaeger LA; Lamar CH
Am J Vet Res; 1992 Sep; 53(9):1685-92. PubMed ID: 1416377
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas.
Vinter-Jensen L; Juhl CO; Teglbjaerg PS; Poulsen SS; Dajani EZ; Nexø E
Gastroenterology; 1997 Oct; 113(4):1367-74. PubMed ID: 9322532
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjögren's syndrome.
Koski H; Konttinen YT; Hietanen J; Tervo T; Malmström M
J Rheumatol; 1997 Oct; 24(10):1930-5. PubMed ID: 9330934
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
11. Chronic systemic treatment with epidermal growth factor induces smooth muscle cell hyperplasia and hypertrophy in the urinary tract of mature Goettingen minipigs.
Vinter-Jensen L; Juhl CO; Dajani EZ; Nielsen K; Djurhuus JC
Br J Urol; 1997 Apr; 79(4):532-8. PubMed ID: 9126080
[TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
13. Glycoproteins in the urothelium and in the urine of the epidermal growth factor induced growing urinary tract in rats.
Vinter-Jensen L; Orntoft TF
Urol Res; 1998; 26(2):97-103. PubMed ID: 9631941
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human epidermal growth factor1-48-induced structural changes in the digestive tract of cynomolgus monkeys (Macaca fascicularis).
Reindel JF; Pilcher GD; Gough AW; Haskins JR; de la Iglesia FA
Toxicol Pathol; 1996; 24(6):669-80. PubMed ID: 9082544
[TBL] [Abstract][Full Text] [Related]
17. Effect of TGF-beta 1, TGF-alpha, and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture.
Ilio KY; Sensibar JA; Lee C
J Androl; 1995; 16(6):482-90. PubMed ID: 8867596
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Jul; 451():1-381. PubMed ID: 12594524
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
